← FDA Drug Approvals (Drugs@FDA)
TASIMELTEON
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: TEVA PHARMS USA INC · Approved 2022-12-12
Drug application
- FDA Application #
ANDA211601- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- TASIMELTEON
- Generic name
- TASIMELTEON
- Active ingredients
- TASIMELTEON
- Dosage form
- CAPSULE
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- TEVA PHARMS USA INC
- Manufacturer
- Teva Pharmaceuticals, Inc.
- First approval
- 2022-12-12
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown